Medical Centre
Diagnostic
Warszawa 73 Chmielna Street (Varso Tower)

When should you consider having a CT scan of the heart?

1. To rule out coronary heart disease in patients at moderate and low risk of developing it.
2. In patients where other diagnostic tests (SPECT, exercise test) have failed to yield a definitive diagnosis, particularly where the patient’s symptoms are atypical.
3. In the monitoring of patients with risk factors for coronary heart disease (smoking, high blood pressure, obesity, age, high cholesterol). A particular group requiring monitoring are people with diabetes, in whom coronary heart disease may be asymptomatic or present with mild symptoms.
4. To check the condition and patency of bypass bridges.
5. When assessing suitability for cardiac surgery.
6. Before the ablation procedure.
7. In patients who refuse to undergo conventional coronary angiography.
8. In cases where coronary artery abnormalities are suspected (including in athletes).
9. To accurately assess cardiac morphology and function in patients with reduced left ventricular ejection fraction (cardiomyopathies) who have contraindications to cardiac MRI.

Are there any advantages to coronary tissue testing over conventional coronary angiography?

1. Minimally invasive – the scan takes 5–10 seconds, does not require a catheter to be inserted directly into the heart, and the contrast agent is administered solely via a venflon inserted into the antecubital vein, just as with any other CT scan.
2. The ability to carry out a qualitative assessment of atherosclerotic plaques and their potential stability or possible risk of rupture.
3. Simultaneous assessment of the anatomy and function of the heart muscle.
4. Diagnostyka sąsiadujących z sercem struktur, bez dodatkowej dawki promieniowania RTG.

WHEN DO WE CARRY OUT MAGNETIC RESONANCE IMAGING OF THE HEART:

• In the assessment of cardiac function, morphology and anatomy.
• patients with heart failure or cardiac dysfunction (assessment of the cause: ischaemic, post-inflammatory, or of unknown aetiology).
• For patients eligible for surgery (angioplasty, coronary bypass surgery) – assessment of life expectancy.
• Assessment of myocardial damage following a heart attack.
• In people with valvular heart disease.
• If a tumour or blood clot is suspected in the heart chambers.
• Before ablation procedures.
• In cases of hypertrophic cardiomyopathy (including athletes).
• In pericardial diseases.

WE PERFORM MRI SCANS OF THE PROSTATE FOR THE FOLLOWING PURPOSES:

• Staging of prostate cancer – including assessment of regional lymph nodes and any infiltration of neighbouring structures.
• Selecting the appropriate type of treatment based on the results of the mpMR scan.
• Monitoring of patients in the low-, medium- and high-risk groups.
• Assessment of the prostate in patients who have undergone treatment and in whom a rise in serum PSA levels has been observed.
• Further diagnostic investigations in patients with suspected prostate cancer, despite negative MRI-guided biopsies.